Lack of asparagine depletion in the cerebrospinal fluid after one intravenous dose of PEG-asparaginase: a window study at initial diagnosis of childhood ALL
Open Access
- 18 September 2003
- journal article
- Published by Springer Nature in Leukemia
- Vol. 17 (11) , 2254-2256
- https://doi.org/10.1038/sj.leu.2403143
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of l-asparaginase in human serumAnalytical Biochemistry, 2002
- A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group studyBlood, 2002
- Transport of nutrients across the choroid plexusMicroscopy Research and Technique, 2000
- Pegylated asparaginase (OncasparTM) in children with ALL: drug monitoring in reinduction according to the ALL/NHL‐BFM 95 protocolsBritish Journal of Haematology, 2000
- L-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. coli L-asparaginase as first exposureAnnals of Oncology, 2000
- Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparationsEuropean Journal Of Cancer, 1996
- Comparative pharmacokinetic studies of three asparaginase preparations.Journal of Clinical Oncology, 1993
- Rapid high-performance liquid chromatographic determination of amino acids in synaptosomal extractsJournal of Chromatography A, 1980